首页>
外国专利>
HISTOLOGICAL MARKERS FOR IDENTIFYING NON-SMALL CELL LUNG CARCINOMA PATIENTS FOR TREATMENT WITH AN ANTI-EGFR DRUG
HISTOLOGICAL MARKERS FOR IDENTIFYING NON-SMALL CELL LUNG CARCINOMA PATIENTS FOR TREATMENT WITH AN ANTI-EGFR DRUG
展开▼
机译:识别非小细胞肺癌抗EGFR药物治疗的组织学标志
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention provides methods for the treatment of lung cancer patients, especially NSCLC with SCC or PLC using a drug against EGFR, such as an anti-EGFR antibody treatment, e.g., cetuximab. In addition, the present invention provides methods for identification or selection of lung cancer patients for the treatment with a drug against EGFR, such as an anti-EGFR antibody treatment, e.g., cetuximab based on histological determinations.
展开▼